Letters: No takers for R&D

Private players should wake up to the fact that research activities are the key to global opportunities and growth

This refers to the Q&A with J G Kulkarni "R&D and innovation find little place in Indian industry" (October 8). India is way behind countries like China, South Korea and Mexico in the field of research and development (R&D). To start with, academics and professionals in our country hardly show any interest in R&D. The shortage of people with doctorate degrees only adds to this problem. As a result, most research centres in India are running without talented research scholars.

It is only the public sector that is involved in R&D activities in India. But we need private participation to enhance competition in the field. Private players should wake up to the fact that research activities are the key to global opportunities and growth. For example, Glenmark has emerged as one of the well-known, research-based pharmaceuticals in India and its revenue has risen to $2.6 billion. Finally, a good amount of money should be earmarked for R&D activities because limited resources often come in the way of growth of research centres.

P Senthil Saravana Durai Mumbai

can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All must have a postal address and telephone number

image
Business Standard
177 22
Business Standard

Letters: No takers for R&D

Private players should wake up to the fact that research activities are the key to global opportunities and growth

Business Standard  |  New Delhi 

This refers to the Q&A with J G Kulkarni "R&D and innovation find little place in Indian industry" (October 8). India is way behind countries like China, South Korea and Mexico in the field of research and development (R&D). To start with, academics and professionals in our country hardly show any interest in R&D. The shortage of people with doctorate degrees only adds to this problem. As a result, most research centres in India are running without talented research scholars.

It is only the public sector that is involved in R&D activities in India. But we need private participation to enhance competition in the field. Private players should wake up to the fact that research activities are the key to global opportunities and growth. For example, Glenmark has emerged as one of the well-known, research-based pharmaceuticals in India and its revenue has risen to $2.6 billion. Finally, a good amount of money should be earmarked for R&D activities because limited resources often come in the way of growth of research centres.

P Senthil Saravana Durai Mumbai

can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg


New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All must have a postal address and telephone number

RECOMMENDED FOR YOU

Letters: No takers for R&D

Private players should wake up to the fact that research activities are the key to global opportunities and growth

This refers to the Q&A with J G Kulkarni "R&D and innovation find little place in Indian industry" (October 8). India is way behind countries like China, South Korea and Mexico in the field of research and development (R&D). To start with, academics and professionals in our country hardly show any interest in R&D. The shortage of people with doctorate degrees only adds to this problem.

This refers to the Q&A with J G Kulkarni "R&D and innovation find little place in Indian industry" (October 8). India is way behind countries like China, South Korea and Mexico in the field of research and development (R&D). To start with, academics and professionals in our country hardly show any interest in R&D. The shortage of people with doctorate degrees only adds to this problem. As a result, most research centres in India are running without talented research scholars.

It is only the public sector that is involved in R&D activities in India. But we need private participation to enhance competition in the field. Private players should wake up to the fact that research activities are the key to global opportunities and growth. For example, Glenmark has emerged as one of the well-known, research-based pharmaceuticals in India and its revenue has risen to $2.6 billion. Finally, a good amount of money should be earmarked for R&D activities because limited resources often come in the way of growth of research centres.

P Senthil Saravana Durai Mumbai

can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201
E-mail: letters@bsmail.in
All must have a postal address and telephone number

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard